New Breast Cancer Study Indicates Low Dose Tamoxifen Is Better Tolerated and May Be Just As Effective As Standard Dose
“A VERY LOW DOSE of tamoxifen—5 mg/d, given for 3 years rather than 5 years—halved the risk of breast cancer recurrence or new lesions over placebo in women with breast intraepithelial neoplasia, without producing the usual toxicities seen with the…
Read more